Literature DB >> 21880640

Can multiple myeloma become a curable disease?

Jesús F San-Miguel, María-Victoria Mateos.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21880640      PMCID： PMC3166092          DOI： 10.3324/haematol.2011.051169

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  24 in total

1.  Immunophenotypic evaluation of the plasma cell compartment in multiple myeloma: a tool for comparing the efficacy of different treatment strategies and predicting outcome.

Authors:  Jesús F San Miguel; Julia Almeida; Gema Mateo; Joan Bladé; Consuelo López-Berges; Dolores Caballero; José Hernández; María Jesús Moro; Javier Fernández-Calvo; Joaquín Díaz-Mediavilla; Luis Palomera; Alberto Orfao
Journal:  Blood       Date:  2002-03-01       Impact factor: 22.113

2.  Maintenance therapy with thalidomide improves survival in patients with multiple myeloma.

Authors:  Michel Attal; Jean-Luc Harousseau; Serge Leyvraz; Chantal Doyen; Cyrille Hulin; Lofti Benboubker; Ibrahim Yakoub Agha; Jean-Henri Bourhis; Laurent Garderet; Brigitte Pegourie; Charles Dumontet; Marc Renaud; Laurent Voillat; Christian Berthou; Gerald Marit; Mathieu Monconduit; Denis Caillot; Bernard Grobois; Herve Avet-Loiseau; Philippe Moreau; Thierry Facon
Journal:  Blood       Date:  2006-07-27       Impact factor: 22.113

3.  Long-term prognostic significance of response in multiple myeloma after stem cell transplantation.

Authors:  Joaquin Martinez-Lopez; Joan Blade; María-Victoria Mateos; Carlos Grande; Adrián Alegre; José García-Laraña; Anna Sureda; Javier de la Rubia; Eulogio Conde; Rafael Martinez; Felipe de Arriba; Maria C Viguria; Joan Besalduch; Rafael Cabrera; José D Gonzalez-San Miguel; José Luis Guzman-Zamudio; Maria Carmen Gomez del Castillo; José Maria Moraleda; Juan C García-Ruiz; Jesús San Miguel; Juan José Lahuerta
Journal:  Blood       Date:  2011-04-11       Impact factor: 22.113

4.  Minimal residual disease monitoring in multiple myeloma: a comparison between allelic-specific oligonucleotide real-time quantitative polymerase chain reaction and flow cytometry.

Authors:  María Eugenia Sarasquete; Ramón García-Sanz; David González; Joaquín Martínez; Gema Mateo; Pilar Martínez; José Maria Ribera; José Mariano Hernández; Juan José Lahuerta; Alberto Orfão; Marcos González; Jesus F San Miguel
Journal:  Haematologica       Date:  2005-10       Impact factor: 9.941

5.  Magnetic resonance imaging in multiple myeloma: diagnostic and clinical implications.

Authors:  Ronald Walker; Bart Barlogie; Jeffrey Haessler; Guido Tricot; Elias Anaissie; John D Shaughnessy; Joshua Epstein; Rudy van Hemert; Eren Erdem; Antje Hoering; John Crowley; Ernest Ferris; Klaus Hollmig; Frits van Rhee; Maurizio Zangari; Mauricio Pineda-Roman; Abid Mohiuddin; Shmuel Yaccoby; Jeffrey Sawyer; Edgardo J Angtuaco
Journal:  J Clin Oncol       Date:  2007-02-12       Impact factor: 44.544

6.  Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia.

Authors:  Andy C Rawstron; Fiona L Bennett; Sheila J M O'Connor; Marwan Kwok; James A L Fenton; Marieth Plummer; Ruth de Tute; Roger G Owen; Stephen J Richards; Andrew S Jack; Peter Hillmen
Journal:  N Engl J Med       Date:  2008-08-07       Impact factor: 91.245

Review 7.  Individualizing treatment of patients with myeloma in the era of novel agents.

Authors:  Jesús San-Miguel; Jean-Luc Harousseau; Douglas Joshua; Kenneth C Anderson
Journal:  J Clin Oncol       Date:  2008-04-21       Impact factor: 44.544

8.  A comparison of allografting with autografting for newly diagnosed myeloma.

Authors:  Benedetto Bruno; Marcello Rotta; Francesca Patriarca; Nicola Mordini; Bernardino Allione; Fabrizio Carnevale-Schianca; Luisa Giaccone; Roberto Sorasio; Paola Omedè; Ileana Baldi; Sara Bringhen; Massimo Massaia; Massimo Aglietta; Alessandro Levis; Andrea Gallamini; Renato Fanin; Antonio Palumbo; Rainer Storb; Giovannino Ciccone; Mario Boccadoro
Journal:  N Engl J Med       Date:  2007-03-15       Impact factor: 91.245

9.  18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.

Authors:  Rosa Fonti; Barbara Salvatore; Mario Quarantelli; Cesare Sirignano; Sabrina Segreto; Fara Petruzziello; Lucio Catalano; Raffaele Liuzzi; Bruno Rotoli; Silvana Del Vecchio; Leonardo Pace; Marco Salvatore
Journal:  J Nucl Med       Date:  2008-01-16       Impact factor: 10.057

10.  Influence of pre- and post-transplantation responses on outcome of patients with multiple myeloma: sequential improvement of response and achievement of complete response are associated with longer survival.

Authors:  Juan José Lahuerta; Maria Victoria Mateos; Joaquin Martínez-López; Laura Rosiñol; Anna Sureda; Javier de la Rubia; José García-Laraña; Rafael Martínez-Martínez; Miguel T Hernández-García; Dolores Carrera; Joan Besalduch; Felipe de Arriba; José María Ribera; Lourdes Escoda; Belén Hernández-Ruiz; Javier García-Frade; Concepción Rivas-González; Adrían Alegre; Joan Bladé; Jesús F San Miguel
Journal:  J Clin Oncol       Date:  2008-11-10       Impact factor: 44.544
View more
  30 in total

1.  Clinical impact of immunophenotypic remission after allogeneic hematopoietic cell transplantation in multiple myeloma.

Authors:  L Giaccone; L Brunello; M Festuccia; M Gilestro; E Maffini; F Ferrando; E Talamo; R Passera; M Boccadoro; P Omedè; B Bruno
Journal:  Bone Marrow Transplant       Date:  2015-02-09       Impact factor: 5.483

2.  CD20 positive cells are undetectable in the majority of multiple myeloma cell lines and are not associated with a cancer stem cell phenotype.

Authors:  Teresa Paíno; Enrique M Ocio; Bruno Paiva; Laura San-Segundo; Mercedes Garayoa; Norma C Gutiérrez; M Eugenia Sarasquete; Atanasio Pandiella; Alberto Orfao; Jesús F San Miguel
Journal:  Haematologica       Date:  2012-02-07       Impact factor: 9.941

Review 3.  European perspective on multiple myeloma treatment strategies in 2014.

Authors:  Heinz Ludwig; Pieter Sonneveld; Faith Davies; Joan Bladé; Mario Boccadoro; Michele Cavo; Gareth Morgan; Javier de la Rubia; Michel Delforge; Meletios Dimopoulos; Hermann Einsele; Thierry Facon; Hartmut Goldschmidt; Philippe Moreau; Hareth Nahi; Torben Plesner; Jesús San-Miguel; Roman Hajek; Pia Sondergeld; Antonio Palumbo
Journal:  Oncologist       Date:  2014-07-25

Review 4.  Consolidation and maintenance therapy for multiple myeloma after autologous transplantation: where do we stand?

Authors:  M Mohty; P G Richardson; P L McCarthy; M Attal
Journal:  Bone Marrow Transplant       Date:  2015-04-20       Impact factor: 5.483

5.  Absence of spontaneous response improvement beyond day +100 after autologous stem cell transplantation in multiple myeloma.

Authors:  C Fernández de Larrea; J Dávila; I Isola; E M Ocio; L Rosiñol; R García-Sanz; M T Cibeira; N Tovar; M Rovira; M V Mateos; J S Miguel; J Bladé
Journal:  Bone Marrow Transplant       Date:  2016-11-21       Impact factor: 5.483

6.  Reply to “Response to “CD20 positive cells are undetectable in the majority of multiple myeloma cell lines and are not associated with a cancer stem cell phenotype”. Haematologica 2012;97(7):1110-1114.

Authors:  Teresa Paíno; Bruno Paiva; Jesús San Miguel
Journal:  Haematologica       Date:  2013-01       Impact factor: 9.941

7.  Multiple myeloma: so much progress, but so many unsolved questions.

Authors:  Philippe Moreau; Stéphane Minvielle
Journal:  Haematologica       Date:  2013-04       Impact factor: 9.941

8.  Conventional Cytogenetics and Interphase Fluorescence In Situ Hybridization Results in Multiple Myeloma: A Turkey Laboratory Analysis of 381 Cases.

Authors:  Cigdem Aydin; Turgay Ulas; Ceren Hangul; Orhan Kemal Yucel; Utku Iltar; Ozan Salim; Deniz Ekinci; Sibel Berker Karauzum
Journal:  Indian J Hematol Blood Transfus       Date:  2019-10-25       Impact factor: 0.900

Review 9.  The Diagnosis and Treatment of Multiple Myeloma.

Authors:  Christian Gerecke; Stephan Fuhrmann; Susanne Strifler; Martin Schmidt-Hieber; Hermann Einsele; Stefan Knop
Journal:  Dtsch Arztebl Int       Date:  2016-07-11       Impact factor: 5.594

10.  Dramatically improved survival in multiple myeloma patients in the recent decade: results from a Swedish population-based study.

Authors:  Sigrun Thorsteinsdottir; Paul W Dickman; Ola Landgren; Cecilie Blimark; Malin Hultcrantz; Ingemar Turesson; Magnus Björkholm; Sigurdur Y Kristinsson
Journal:  Haematologica       Date:  2018-03-22       Impact factor: 9.941
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.